Sage Journals: Discover world-class research

Abstract

We investigated the association between the catechol-O-methyltransferase (COMT) Val¹⁵⁸-Met (rs4680) genotype and both subjective and objective treatment responses to methylphenidate in Korean children with attention-deficit/hyperactivity disorder (ADHD). We enrolled 120 medication-naïve children with ADHD in an open-label, 8-week trial of methylphenidate. The participants were genotyped and evaluated using the Clinical Global Impression Scale and the ADHD Rating Scale-IV (ADHD-RS), and completed the Continuous Performance Test (CPT) before and after treatment. We found a significant association between the COMT Val/Val genotype and a good response, in terms of hyperactive-impulsive scores on the ADHD-RS (odds ratio (OR) = 2.61; p = 0.044) and response-time variability on the CPT (OR = 2.66; p = 0.028). The association of the COMT Val/Val genotype with a good response, in terms of response time variability, was significant in both the sub-sample of combined-type (OR = 3.45; p = 0.026) and sub-sample of inattentive-type (OR = 5.52; p = 0.029); but the association with a good response in terms of hyperactive-impulsive scores was not significant in sub-sample analyses. Although the reported nominally significant associations did not stay significant after correcting for multiple testing, our results support previous findings about the possible involvement of the COMT (Val¹⁵⁸-Met) polymorphism in the treatment response to methylphenidate in children with ADHD.

Keywords

Attention deficit hyperactivity disorder catechol-O-methyltransferase drug response effectiveness genotype methylphenidate

Get full access to this article

View all access options for this article.

References

Arnsten

(2005) Neurobiology of executive functions: Catecholamine influences on prefrontal cortical functions. Biol Psychiatry 57: 1377–1384.

Biederman

Faraone

(2005) Attention-deficit hyperactivity disorder. Lancet 366: 237–248.

Brewis

(2002) Social and biological measures of hyperactivity and inattention: Are they describing similar underlying constructs of child behavior? Social Biol 49: 99–115.

Castellanos

Tannock

(2002) Neuroscience of attention-deficit/hyperactivity disorder: The search for endophenotypes. Nat Rev Neurosci 3: 617–628.

Cheon

Jun

Cho

(2008) Association of the catechol-O-methyltransferase polymorphism with methylphenidate response in a classroom setting in children with attention-deficit hyperactivity disorder. Int Clin Psychopharmacol 23: 291–298.

Del Campo

Chamberlain

Sahakian

et al. (2011) The roles of dopamine and noradrenaline in the pathophysiology and treatment of attention-deficit/hyperactivity disorder. Biol Psychiatry 69: e145–157.

Doyle

Faraone

Seidman

et al. (2005) Are endophenotypes based on measures of executive functions useful for molecular genetic studies of ADHD? J Child Psychol Psychiatry 46: 774–803.

Faraone

Biederman

(1998) Neurobiology of attention-deficit hyperactivity disorder. Biol Psychiatry 44: 951–958.

Froehlich

Epstein

Nick

et al. (2011) Pharmacogenetic predictors of methylphenidate dose-response in attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 50: 1129–1139.

10.

Froehlich

Mcgough

Stein

(2010) Progress and promise of attention-deficit hyperactivity disorder pharmacogenetics. CNS Drugs 24: 99–117.

11.

Greenberg

Waldman

(1993) Developmental normative data on the Test of Variables of Attention (TOVA). J Child Psychol Psychiatry 34: 1019–1030.

12.

Guy

(1976) ECDEU Assessment Manual for Psychopharmacology, Revised. Rockville, MD: US Department of Health, Education, and Welfare.

13.

Hannestad

Gallezot

Planeta-Wilson

et al. (2010) Clinically relevant doses of methylphenidate significantly occupy norepinephrine transporters in humans in vivo. Biol Psychiatry 68: 854–860.

14.

Joober

Gauthier

Lal

et al. (2002) Catechol-O-methyltransferase Val-108/158-Met gene variants associated with performance on the Wisconsin Card Sorting Test. Arch Gen Psychiatry 59: 662–663.

15.

Kereszturi

Tarnok

Bognar

et al. (2008) Catechol-O-methyltransferase Val-158Met polymorphism is associated with methylphenidate response in ADHD children. Am J Med Genet B Neuropsychiatr Genet 147B: 1431–1435.

16.

Lachman

Papolos

Saito

et al. (1996) Human catechol-O-methyltransferase pharmacogenetics: Description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 6: 243–250.

17.

Leonard

McCartan

White

et al. (2004) Methylphenidate: A review of its neuropharmacological, neuropsychological and adverse clinical effects. Hum Psychopharmacol 19: 151–180.

18.

Lim

Kim

Kim Do

et al. (2010) Genetic polymorphism of catechol-O-methyltransferase and cytochrome P450c17α in preeclampsia. Pharmacogenet Genomics 20: 605–610.

19.

McGough

McCracken

Loo

et al. (2009) A candidate gene analysis of methylphenidate response in attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 48: 1155–1164.

20.

Malhotra

Kestler

Mazzanti

et al. (2002) A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition. Am J Psychiatry 159: 652–654.

21.

Mattay

Goldberg

Fera

et al. (2003) Catechol O-methyltransferase Val-158-Met genotype and individual variation in the brain response to amphetamine. Proc Natl Acad Sci USA 100: 6186–6191.

22.

Napolitano

Cesura

Da Prada

(1995) The role of monoamine oxidase and catechol O-methyltransferase in dopaminergic neurotransmission. J Neural Transm 45: S35–45.

23.

Sengupta

Grizenko

Schmitz

et al. (2008) COMT Val-108/158Met polymorphism and the modulation of task-oriented behavior in children with ADHD. Neuropsychopharmacol 33: 3069–3077.

24.

Shah

Cork

Chowdhury

(2005) ADHD: Assessment and intervention. Community Pract 78: 129–132.

25.

Shin

Cho

Chun

et al. (2000) A study of the development and standardization of ADHD diagnostic system. Korean J Child Adol Psychiatr 11: 91–99.

26.

Noh

Kim

et al. (2002) The reliability and validity of Korean parent and teacher ADHD Rating Scale. J Korean Neuropsychiatr Assoc 41: 283–289.

Catechol-O-methyltransferase Val 158 -Met polymorphism and a response of hyperactive-impulsive symptoms to methylphenidate: A replication study from South Korea

Abstract

Keywords

Get full access to this article

References